SCHEMBL15918731

SCHEMBL15918731

Fc1cc(N2CCCC2)ccn1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHKA P35790 1/20 0.52
▸ HRH4 Q9H3N8 7/20 0.51
▸ ELOVL1 Q9BW60 1/20 0.50
▸ TERT O14746 3/20 0.44
▸ DHFR P00374 1/20 0.41
▸ IP6K1 Q92551 2/20 0.40
▸ MAP4K4 O95819 1/20 0.39
▸ S100B P04271 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ PKM P14618 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29529691 0.98 HRH4 (0.54) CHKAHRH4ELOVL1TERTDHFR
SCHEMBL21807915 0.83 HRH4 (0.59) HRH4MEN1GAAMAPTMAPK1
SCHEMBL21807926 0.83 LMNA (0.46) MEN1ALDH1A1LMNAMAPTALOX15
SCHEMBL31051506 0.83 LMNA (0.46) MEN1ALDH1A1LMNAMAPTALOX15
SCHEMBL31051504 0.83 HRH4 (0.59) HRH4MEN1GAAMAPTMAPK1
SCHEMBL27102997 0.83 ADRB2 (0.56) HRH4ALDH1A1MAPTHTT
Hydrochloric Acid SCHEMBL23302654 0.82 ADRB2 (0.55) HRH4ALDH1A1MAPTHTT
Hydrochloric Acid SCHEMBL29882400 0.82 ADRB2 (0.55) HRH4ALDH1A1MAPTHTT
SCHEMBL24126677 0.77 ACHE (0.41) HRH4
SCHEMBL27106846 0.77 WNT3A (0.52) MEN1GAAMAPTALOX15KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107624113-A Tetrahydropyridopyrimidines and tetrahydropyridopyridines as inhibitors of HBsAg (HBV surface antigen) and HBV DNA production for the treatment of hepatitis B virus infection 豪夫迈·罗氏有限公司 2018-01-23 — — CN claimed
WO-2021256569-A1 CONDENSED RING COMPOUNDS THAT INHIBIT H-PGDS 佐藤製薬株式会社 2021-12-23 — — WO disclosed
CN-107624113-A Tetrahydropyridopyrimidines and tetrahydropyridopyridines as inhibitors of HBsAg (HBV surface antigen) and HBV DNA production for the treatment of hepatitis B virus infection 豪夫迈·罗氏有限公司 2018-01-23 — — CN disclosed
EP-2948442-B1 PYRROLIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF BOEHRINGER INGELHEIM INT (DE) 2016-10-26 — — EP disclosed
WO-2014114578-A1 PYRROLIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-07-31 — — WO disclosed
Send feedback